Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pit'ha

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Vnitrni Lekarstvi|October 25, 2000
[Vasoneuroses]J Pit'ha, I Oliva
Vnitrni Lekarstvi|June 21, 2007
[CRP--a marker of a pro-inflammatory state and cardiovascular risk]R Poledne, Z Valenta, J Pit'ha
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|August 1, 2009
[Disadvantages of unilateral videothoracoscopic thymectomy]J Tvrdon, J Schützner, J Pit'ha
Vnitrni Lekarstvi|August 1, 1993
[An unusual cause of recurrent septic states]J Sochman, M Rocek, J Kakác, et al.
Vnitrni Lekarstvi|June 2, 2006
[Simvor in the treatment of hyperlipoproteinaemia]R Ceska, T Kvasnicka, V Bláha, et al.
Casopis Lekaru Ceskych|May 22, 2003
[CD14 (C-159-->T) polymorphism and levels of C-reactive protein]J A Hubácek, P Stávek, J Pit'ha, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|May 1, 1996
[Correlation of computer tomography findings with surgical findings in patients with myasthenia gravis]S Adámek, J Schützner, Z Seidl, et al.
Casopis Lekaru Ceskych|July 4, 2001
[Plasma level of Lp(a) in patients with myocardial infarct is not controlled by the apolipoprotein E gene polymorphism]J A Hubácek, P Stávek, J Pit'ha, et al.
Journal of Biomedicine & Biotechnology|March 20, 2010
Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravisM Blaha, J Pit'ha, V Blaha, et al.
Circulation|June 29, 1999
C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarctionJ A Hubacek, G Rothe, J Pit'ha, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Vnitrni Lekarstvi|October 25, 2000
[Vasoneuroses]J Pit'ha, I Oliva
Vnitrni Lekarstvi|June 21, 2007
[CRP--a marker of a pro-inflammatory state and cardiovascular risk]R Poledne, Z Valenta, J Pit'ha
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|August 1, 2009
[Disadvantages of unilateral videothoracoscopic thymectomy]J Tvrdon, J Schützner, J Pit'ha
Vnitrni Lekarstvi|August 1, 1993
[An unusual cause of recurrent septic states]J Sochman, M Rocek, J Kakác, et al.
Vnitrni Lekarstvi|June 2, 2006
[Simvor in the treatment of hyperlipoproteinaemia]R Ceska, T Kvasnicka, V Bláha, et al.
Casopis Lekaru Ceskych|May 22, 2003
[CD14 (C-159-->T) polymorphism and levels of C-reactive protein]J A Hubácek, P Stávek, J Pit'ha, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|May 1, 1996
[Correlation of computer tomography findings with surgical findings in patients with myasthenia gravis]S Adámek, J Schützner, Z Seidl, et al.
Casopis Lekaru Ceskych|July 4, 2001
[Plasma level of Lp(a) in patients with myocardial infarct is not controlled by the apolipoprotein E gene polymorphism]J A Hubácek, P Stávek, J Pit'ha, et al.
Journal of Biomedicine & Biotechnology|March 20, 2010
Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravisM Blaha, J Pit'ha, V Blaha, et al.
Circulation|June 29, 1999
C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarctionJ A Hubacek, G Rothe, J Pit'ha, et al.
Pageof 2